Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome

Int J Hematol. 2008 Nov;88(4):457-459. doi: 10.1007/s12185-008-0180-6. Epub 2008 Oct 23.

Authors

Nana Sasaki¹, Junya Kuroda², Eri Kawata³, Teruaki Akaogi³, Miki Kiyota³, Yutaka Kobayashi³, Masafumi Taniwaki¹

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
² Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan. junkuro@koto.kpu-m.ac.jp.
³ Division of Hematology, Kyoto Second Red Cross Hospital, 355-5, Haruobi-cho, Kamigyo-ku, Kyoto, 602-8026, Japan.

PMID: 18941866
DOI: 10.1007/s12185-008-0180-6

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Inflammatory Agents / administration & dosage
Blood Cell Count
Bone Marrow / pathology
Cyclosporine / administration & dosage
Female
Humans
Immunosuppressive Agents / administration & dosage
Myelodysplastic Syndromes / blood
Myelodysplastic Syndromes / complications*
Myelodysplastic Syndromes / pathology
Myelodysplastic Syndromes / therapy*
Plasma Exchange
Prednisolone / administration & dosage
Pregnancy
Pregnancy Complications, Hematologic / blood
Pregnancy Complications, Hematologic / pathology
Pregnancy Complications, Hematologic / therapy*
Purpura, Thrombotic Thrombocytopenic / blood
Purpura, Thrombotic Thrombocytopenic / complications*
Purpura, Thrombotic Thrombocytopenic / drug therapy
Purpura, Thrombotic Thrombocytopenic / pathology
Purpura, Thrombotic Thrombocytopenic / therapy*

Substances

Anti-Inflammatory Agents
Immunosuppressive Agents
Cyclosporine
Prednisolone